Similarities and differences between native HIV-1 envelope glycoprotein trimers and stabilized soluble trimer mimetics
A. Torrents de la Pena, K. Rantalainen, C. A. Cottrell, J. D. Allen, M. J. van Gils, J. L. Torres, M. Crispin, R. W. Sanders, A. B. Ward
Abstract
The HIV-1 envelope glycoprotein (Env) trimer is located on the surface of the virus and is the target of broadly neutralizing antibodies (bNAbs). Recombinant native-like soluble Env trimer mimetics, such as SOSIP trimers, have taken a central role in HIV-1 vaccine research aimed at inducing bNAbs. We therefore performed a direct and thorough comparison of a full-length native Env trimer containing the transmembrane domain and the cytoplasmic tail, with the sequence matched soluble SOSIP trimer, both based on an early Env sequence (AMC011) from an HIV+ individual that developed bNAbs. The structures of the full-length AMC011 trimer bound to either bNAb PGT145 or PGT151 were very similar to the structures of SOSIP trimers. Antigenically, the full-length and SOSIP trimers were comparable, but in contrast to the full-length trimer, the SOSIP trimer did not bind at all to non-neutralizing antibodies, most likely as a consequence of the intrinsic stabilization of the SOSIP trimer. Furthermore, the glycan composition of full-length and SOSIP trimers was similar overall, but the SOSIP trimer possessed slightly less complex and less extensively processed glycans, which may relate to the intrinsic stabilization as well as the absence of the membrane tether. These data provide insights into how to best use and improve membrane-associated full-length and soluble SOSIP HIV-1 Env trimers as immunogens.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Enhancing glycan occupancy of soluble HIV-1 envelope trimers to mimic the native viral spike
R. Derking, J. D. Allen, … R. W. Sanders·bioRxiv·Jul 2, 2020
- Design and immunogenicity of an HIV-1 clade C pediatric envelope glycoprotein stabilized by multiple platforms
Sanjeev Kumar, Iván del Moral-Sánchez, … Kalpana Luthra·VaccinesPeer-reviewed·Jan 22, 2025
- Engineering well-expressed, V2-immunofocusing HIV-1 envelope glycoprotein membrane trimers for use in heterologous prime-boost vaccine regimens
J. M. Binley, E. Crooks, … L. Verkoczy·bioRxiv·Jul 20, 2021
- Structure-guided design of native-like HIV Env Single Chain Trimers for enhanced stability, immunogenicity, and versatile vaccine delivery
Xuduo Li, Ipsita Krishnamurthy, … Raiees Andrabi·bioRxiv·Oct 25, 2025
- Triple tandem trimer immunogens for HIV-1 and influenza nucleic acid-based vaccines
I. del Moral-Sanchez, E. G. Wee, … R. W. Sanders·bioRxiv·Aug 27, 2023
- CD4 binding-site antibodies induced by a subtype B HIV-1 envelope trimer
A. Schorcht, T. L. G. M. van den Kerkhof, … R. W. Sanders·bioRxiv·Mar 23, 2022